W

ASHINGTON — One of the first big issues Scott Gottlieb will have to weigh in on if confirmed as Food and Drug commissioner is what to do about the booming field of diagnostic tests.

Gottlieb, a physician and libertarian scholar, has been lukewarm on whether to regulate in vitro clinical tests, a category that includes finished products such as test kits and platforms as well as laboratory developed tests (LDTs), which are lab protocols used for diagnostics.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.